Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer extends tender offer for King Pharmaceuticals, more time needed for conditions
Yahoo/AP
Thursday, December 16, 2010 - 11:58am
tags:
Pfizer, King, M&A
J&J names vice-chairmen
Marketwatch
Thursday, December 16, 2010 - 11:38am
tags:
JNJ
Novartis Is Eye-Care King After Acquiring Alcon
Forbes
Thursday, December 16, 2010 - 11:33am
tags:
Novartis, Alcon, M&A, eye health
Novartis' Zometa Disappoints
Yahoo/Zacks.com
Thursday, December 16, 2010 - 11:31am
tags:
Novartis, Zometa, AZURE
Does This Mean Hospira Will Burn You?
Motley Fool
Thursday, December 16, 2010 - 11:29am
tags:
Hospira, Teva Pharmaceuticals, Impax, Pfizer
Cypress jumps on buyout deal
Marketwatch
Wednesday, December 15, 2010 - 10:35am
tags:
M&A, Cypress Bioscience, Ramius
Affymetrix says judge dismissed 2 patent infringement lawsuits brought by rival Illumina
Yahoo/AP
Wednesday, December 15, 2010 - 10:32am
tags:
patents, Affymetrix, Illumina, Patent Infringement
Lexicon Pharmaceuticals Shares Plunged: What You Need to Know
Motley Fool
Wednesday, December 15, 2010 - 10:31am
tags:
Lexicon Pharmaceuticals, rheumatoid arthritis, LX2931
Sanofi’s Plavix Should Be Option for Stroke Patients, NICE Says
Bloomberg
Wednesday, December 15, 2010 - 10:29am
tags:
Sanofi, NICE, UK, stroke, Plavix
Novartis Buys Rest of Alcon Stake for $12.9B
TheStreet.com
Wednesday, December 15, 2010 - 10:29am
tags:
Novartis, Alcon, M&A
3 Ways to Play Biotech With Options
Motley Fool
Tuesday, December 14, 2010 - 9:47pm
tags:
biotech, options, Avanir, Orexigen, Exelixis, Momenta
Amgen Celebration May be Premature
Minyanville
Tuesday, December 14, 2010 - 9:46pm
tags:
Amgen, prostate cancer, Xgeva
Watson Pharma Ruling Will Embolden An Already Agressive FTC
Forbes
Tuesday, December 14, 2010 - 9:44pm
tags:
FTC, Watson Pharmaceuticals
Pfizer Business Units to Report Directly to Read
Bloomberg
Tuesday, December 14, 2010 - 5:35pm
tags:
Pfizer, Ian Read, Pharma CEOs
Drug Cocktails for Cancer, Heart Disease Get Streamlined Review From FDA
Bloomberg
Tuesday, December 14, 2010 - 5:34pm
tags:
FDA, Roche, Sanofi, drug cocktails, cancer, Novartis, Pfizer, GSK, Merck, heart disease
Pfizer Joins the E-Sampling Crowd: How it Assuaged Sales Reps’ Concerns
WSJ Online
Tuesday, December 14, 2010 - 5:33pm
tags:
e-sampling, Pfizer, drug reps
Legal Experts React to Health Care Ruling
National Review
Tuesday, December 14, 2010 - 12:44pm
tags:
healthcare reform
Obamacare Defenders May Have Precedent They Need
Forbes
Tuesday, December 14, 2010 - 12:28pm
tags:
healthcare reform
Critics eye Mass. Health after Obamacare ruling
Boston Herald
Tuesday, December 14, 2010 - 12:25pm
tags:
healthcare reform
Pfizer names Lorch after Kindler exit
FT.com
Tuesday, December 14, 2010 - 11:28am
tags:
Pfizer, Jeff Kindler, George Lorch

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.